WO2018050942A8 - Nanopartículas con interiores protegidos, y métodos de uso de las mismas - Google Patents

Nanopartículas con interiores protegidos, y métodos de uso de las mismas Download PDF

Info

Publication number
WO2018050942A8
WO2018050942A8 PCT/ES2017/070617 ES2017070617W WO2018050942A8 WO 2018050942 A8 WO2018050942 A8 WO 2018050942A8 ES 2017070617 W ES2017070617 W ES 2017070617W WO 2018050942 A8 WO2018050942 A8 WO 2018050942A8
Authority
WO
WIPO (PCT)
Prior art keywords
nanoparticles
methods
same
therapeutic molecules
peptide
Prior art date
Application number
PCT/ES2017/070617
Other languages
English (en)
French (fr)
Other versions
WO2018050942A1 (es
Inventor
Maria Josefa ALONSO FERNANDEZ
Zhigao Niu
Manuel Jesus SANTANDER ORTEGA
Original Assignee
Universidade De Santiagod E Compostela
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidade De Santiagod E Compostela filed Critical Universidade De Santiagod E Compostela
Publication of WO2018050942A1 publication Critical patent/WO2018050942A1/es
Publication of WO2018050942A8 publication Critical patent/WO2018050942A8/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Nanopartículas con interiores protegidos, y métodos de uso de las mismas. La presente invención se refiere en general a partículas, incluyendo nanopartículas, por ejemplo, para la administración de fármacos u otras aplicaciones. Ciertos aspectos de la presente invención se dirigen generalmente a partículas, tales como nanopartículas, que comprende una parte interior y un recubrimiento. La parte interior puede contener insulina u otras moléculas terapéuticas para la administración a un ser vivo. En algunos casos, las moléculas pueden estar electrostáticamente complejadas con un péptido de carga opuesta, tal como un oligoarginina, u otras especies. Las especies típicamente están cargadas positivamente, por ejemplo, para moléculas terapéuticas ionizados negativamente a pH neutro. Las moléculas terapéuticas pueden ser también soluble en agua. En algunos casos, el péptido puede conjugarse con una porción hidrófoba, tales como colesterol, ácido láurico, o una cadena de ácido graso.
PCT/ES2017/070617 2016-09-19 2017-09-18 Nanopartículas con interiores protegidos, y métodos de uso de las mismas WO2018050942A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201631221A ES2664584B2 (es) 2016-09-19 2016-09-19 Nanoparticulas con interiores protegidos, y métodos de uso de las mismas
ESP201631221 2016-09-19

Publications (2)

Publication Number Publication Date
WO2018050942A1 WO2018050942A1 (es) 2018-03-22
WO2018050942A8 true WO2018050942A8 (es) 2018-05-11

Family

ID=61617373

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2017/070617 WO2018050942A1 (es) 2016-09-19 2017-09-18 Nanopartículas con interiores protegidos, y métodos de uso de las mismas

Country Status (3)

Country Link
US (1) US10471020B2 (es)
ES (1) ES2664584B2 (es)
WO (1) WO2018050942A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2664584B2 (es) 2016-09-19 2018-12-13 Universidade De Santiago De Compostela Nanoparticulas con interiores protegidos, y métodos de uso de las mismas
CN109260174B (zh) * 2018-09-04 2021-10-15 中山大学 一种治疗性蛋白纳米颗粒的高通量制备方法
JP2022540665A (ja) * 2019-07-12 2022-09-16 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 機能化されたナノ粒子および細菌感染症の治療におけるその使用
CN113075342B (zh) * 2020-01-04 2024-02-27 东莞市东阳光仿制药研发有限公司 一种分离检测德谷胰岛素侧链有关物质的方法
CN114617974B (zh) * 2020-12-10 2023-10-03 中国科学院苏州纳米技术与纳米仿生研究所 一种多肽白蛋白纳米粒及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005032593A1 (ja) 2003-10-01 2005-04-14 Japan Science And Technology Agency 核移行能を有するポリアルギニン修飾リポソーム
US8709472B1 (en) 2007-11-13 2014-04-29 Abbott Cardiovascular Systems Inc. Bioactive agent-loaded heart-targeting nanoparticles
US9566349B2 (en) 2010-10-14 2017-02-14 Rutgers, The State University Of New Jersey Intestinal peptide targeting ligands
ES2385995B2 (es) 2011-01-10 2013-05-21 Universidade De Santiago De Compostela Nanocápsulas con cubierta polimérica
EP2886128A1 (en) 2013-12-20 2015-06-24 Nanobiotix Pharmaceutical composition comprising nanoparticles, preparation and uses thereof
CN104434806B (zh) 2014-11-06 2017-05-03 中国人民解放军第四军医大学 一种具有高载药量及主动靶向效应的脂质混合plga纳米粒
CN104497147B (zh) 2014-12-23 2018-07-03 四川大学 一种双受体识别的串联型穿膜肽修饰的肿瘤靶向纳米递药系统
ES2664584B2 (es) 2016-09-19 2018-12-13 Universidade De Santiago De Compostela Nanoparticulas con interiores protegidos, y métodos de uso de las mismas

Also Published As

Publication number Publication date
ES2664584B2 (es) 2018-12-13
ES2664584A1 (es) 2018-04-20
US10471020B2 (en) 2019-11-12
US20180078510A1 (en) 2018-03-22
WO2018050942A1 (es) 2018-03-22

Similar Documents

Publication Publication Date Title
WO2018050942A8 (es) Nanopartículas con interiores protegidos, y métodos de uso de las mismas
WO2018067302A3 (en) Therapeutic effects of cellular delivery of small molecules and macromolecules with liposomal spherical nucleic acids
WO2017049245A3 (en) Compounds and compositions for intracellular delivery of therapeutic agents
MX2019005287A (es) Lipidos cationicos para suministro de acido nucleico y su preparacion.
WO2017223085A3 (en) Compositions and methods for delivery of biomacromolecule agents
EP4036079A3 (en) Compounds and compositions for intracellular delivery of agents
BR112016009643A8 (pt) composição nanoparticulada, célula dendrítica artificial, método para estimular ou intensificar uma resposta imune e método para tratar câncer
WO2015011633A8 (en) Compositions and methods for delivering messenger rna
WO2015152693A3 (ko) 신규 이중 나선 올리고 rna 및 이를 포함하는 섬유증 또는 호흡기 질환의 예방 또는 치료용 약학조성물
MX2019005300A (es) Polimeros enlazados al proton para administracion oral.
MX2021004558A (es) Polimeros de union a protones para administracion oral.
WO2013089394A3 (ko) 고분자 나노입자 수용액 조성물 및 그 제조방법
NZ755442A (en) Topical cyclosporine-containing formulations and uses thereof
PH12017500098A1 (en) Suspension compositions of cyclosporin a for subconjunctival and periocular injection
WO2015091885A3 (en) Microcapsules with polymeric coating comprising a lipid and an active agent
WO2015153805A3 (en) Targeted polymerized nanoparticles for cancer treatment
WO2018029656A3 (en) Methods for making and using therapeutic exosomes
EA201792674A1 (ru) Способ образования наночастиц циклоспорина а/циклодекстрина
EA201791138A1 (ru) Фармацевтическая композиция, ее приготовление и применения
PH12015502556A1 (en) Modified release formulation
WO2015157322A3 (en) Anti-nme antibody
WO2020217231A3 (en) Magnetic nanosystem and method to produce the nanosystem
WO2016140702A8 (en) Display platform from bacterial spore coat proteins
WO2016183223A3 (en) Targeted protein contrast agents, methods of making, and uses thereof
WO2018229093A8 (en) NANOPARTICLES AS DELIVERY VEHICLES OF ACTIVE PRINCIPLES AND METHODS OF PRODUCING SAME

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17850342

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17850342

Country of ref document: EP

Kind code of ref document: A1